| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/01/1994 | US5360733 Genetic engineering; leukosialin acceptor molecule |
| 11/01/1994 | US5360728 Modified apoaequorin having increased bioluminescent activity |
| 11/01/1994 | US5360726 Fusing DNA sequences; translocation to endoplasmic reticulum; gene expression; insecticidal |
| 11/01/1994 | US5360716 Human tumor necrosis factor αspecific monoclonal antibody and method for detecting human tumor necrosis factor α |
| 11/01/1994 | US5360715 Detectors with DNA sequences and method of determinimg whether cells are neoplastic |
| 10/31/1994 | CA2122202A1 Fema gene of staphylococcus epidermidis, fema protein, and vectors and microorganisms comprising the fema gene |
| 10/31/1994 | CA2122201A1 Femb gene of staphylococcus epidermidis, femb protein, and vectors and microorganisms comprising the femb gene |
| 10/30/1994 | CA2122227A1 Peptide analogs as irreversible interleukin-1.beta. protease inhibitors |
| 10/29/1994 | CA2121990A1 Antibody-drug conjugates |
| 10/27/1994 | WO1994024566A1 Immunoassay and test kit for thrombin-antithrombin iii complex |
| 10/27/1994 | WO1994024565A1 Hepatitis c virus immunodiagnostic antigens and antibodies |
| 10/27/1994 | WO1994024313A1 Methods for nucleic acid detection, sequencing, and cloning using exonuclease |
| 10/27/1994 | WO1994024301A1 Expression of heterologous genes according to a targeted expression profile |
| 10/27/1994 | WO1994024298A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 10/27/1994 | WO1994024297A1 Defective recombinant adenoviruses for gene therapy of tumours |
| 10/27/1994 | WO1994024296A2 Recombinant bovine herpesvirus type 1 vaccines |
| 10/27/1994 | WO1994024295A1 Exogenous regulation of gene expression in plants |
| 10/27/1994 | WO1994024291A2 Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation |
| 10/27/1994 | WO1994024290A1 Fusion proteins between antigenic amino acid sequences and beta-2-microglobulin |
| 10/27/1994 | WO1994024289A1 Method for addressing proteins in yeast peroxisomes |
| 10/27/1994 | WO1994024285A1 Macrophage inflammatory protein variants |
| 10/27/1994 | WO1994024284A1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 10/27/1994 | WO1994024283A2 A mammalian guanine nucleotide binding protein with an adp-rybosylation factor domain |
| 10/27/1994 | WO1994024282A1 A human t-cell receptor of the g-protein coupled receptor family |
| 10/27/1994 | WO1994024281A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 10/27/1994 | WO1994024280A1 Expression of beta-2-microglobulin in pichia pastoris |
| 10/27/1994 | WO1994024279A2 Agents for the prevention and treatment of huntington's disease and other neurological disorders |
| 10/27/1994 | WO1994024276A1 Glutamylcysteine synthetase light subunit |
| 10/27/1994 | WO1994024275A1 Model for gonococcal infection |
| 10/27/1994 | WO1994024274A1 Isolation, selection and propagation of animal transgenic stem cells |
| 10/27/1994 | WO1994024268A1 Recombinant avian adenovirus vector |
| 10/27/1994 | WO1994024267A1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 10/27/1994 | WO1994024266A1 Transgenic animal models for alzheimer's disease |
| 10/27/1994 | WO1994024264A1 New bacillus thuringiensis strains and their insecticidal proteins |
| 10/27/1994 | WO1994024167A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
| 10/27/1994 | WO1994024166A1 Unique sperm antigens and methods of use |
| 10/27/1994 | WO1994024165A1 An fk-506 and rapamycin specific binding immunophilin |
| 10/27/1994 | WO1994024162A1 NUCLEOTIDE SEQUENCES CODING FOR THE BOVINE β3-ADRENERGIC RECEPTOR, AND APPLICATIONS THEREOF |
| 10/27/1994 | WO1994024161A1 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 10/27/1994 | WO1994024160A2 Erythropoietin muteins with enhanced activity |
| 10/27/1994 | WO1994024158A1 Cellulose binding domain |
| 10/27/1994 | WO1994024157A1 A method of detecting the presence of and converting of a polypeptide |
| 10/27/1994 | WO1994024156A1 Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical, prophylactic and diagnostic applications |
| 10/27/1994 | WO1994024155A1 The therapeutic use of clostridium difficile toxin a |
| 10/27/1994 | WO1994024153A1 Cyclic compounds and compositions which inhibit bone resorption |
| 10/27/1994 | WO1994024148A1 Modified protein and peptide pharmaceuticals |
| 10/27/1994 | WO1994024080A1 Progesterone receptor agonist and antagonists |
| 10/27/1994 | WO1994023760A1 Transgenic animal model for autoimmune diseases |
| 10/27/1994 | WO1994023758A1 Radiolabeled compounds for thrombus imaging |
| 10/27/1994 | WO1994023756A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 10/27/1994 | WO1994023746A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 10/27/1994 | WO1994023745A1 35/31 kda subunit of the entamoeba histolytica adherence lectin |
| 10/27/1994 | WO1994023744A1 Recombinant cytomegalovirus vaccine |
| 10/27/1994 | WO1994023740A1 Conjugates of growth factor and bone resorption inhibitor |
| 10/27/1994 | WO1994023738A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 10/27/1994 | WO1994023736A1 Method of treating depression using neurotrophins |
| 10/27/1994 | WO1994023735A1 Novel polypeptide having factor xa inhibitory activity |
| 10/27/1994 | WO1994023730A1 Method of treating hepatitis b infection |
| 10/27/1994 | WO1994023728A1 Immunogenic cancer proteins and peptides and method of use |
| 10/27/1994 | WO1994023722A1 Hydrocortisone buffering activity |
| 10/27/1994 | WO1994023709A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis |
| 10/27/1994 | WO1994023638A2 Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome |
| 10/27/1994 | WO1994023582A1 Adenoviral vectors including dna encoding lung surfactant protein |
| 10/27/1994 | WO1994023570A1 New regulatory elements for gene expression |
| 10/27/1994 | WO1994023561A1 Ph genes and their uses |
| 10/27/1994 | WO1994020617A3 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 10/27/1994 | WO1994019465A3 Novel dna- binding regulator of c-myc expression which binds to the far upstream elements (fuse) and cdna therefor |
| 10/27/1994 | WO1994019463A3 Developmental tyrosine kinases and their ligands |
| 10/27/1994 | WO1994016068A3 Allergenic proteins and peptides from dog dander and uses therefor |
| 10/27/1994 | WO1994010313A3 Interferon tau compositions and methods of use |
| 10/27/1994 | DE4313232A1 Method for the determination of the activity of endothelin converting enzyme (ECE) |
| 10/27/1994 | CA2161229A1 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 10/27/1994 | CA2161122A1 Biocompatible implant for expression and secretion of a therapeutic compound in vivo |
| 10/27/1994 | CA2161097A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 10/27/1994 | CA2161095A1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 10/27/1994 | CA2161089A1 Isolation, selection and propagation of animal transgenic stem cells |
| 10/27/1994 | CA2161088A1 Expression of heterologous genes according to a targeted expression profile |
| 10/27/1994 | CA2161014A1 Methods for nucleic acid detection, sequencing, and cloning using exonuclease |
| 10/27/1994 | CA2160878A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 10/27/1994 | CA2160713A1 Immunogenic cancer proteins and peptides and method of use |
| 10/27/1994 | CA2160670A1 Cellulose binding domain |
| 10/27/1994 | CA2160663A1 A method of detecting the presence of and converting of a polypeptide |
| 10/27/1994 | CA2160583A1 Recombinant cytomegalovirus vaccine |
| 10/27/1994 | CA2160579A1 Ph genes and their uses |
| 10/27/1994 | CA2160537A1 Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical prophylactic and diagnostic applications |
| 10/27/1994 | CA2160155A1 Model for gonococcal infection |
| 10/27/1994 | CA2160136A1 Adenoviral vectors including dna encoding lung surfactant protein |
| 10/27/1994 | CA2160120A1 Radiolabeled compounds for thrombus imaging |
| 10/27/1994 | CA2159813A1 A human t-cell receptor of the g-protein coupled receptor family |
| 10/27/1994 | CA2159218A1 Novel polypeptide having factor xa inhibitory activity |
| 10/27/1994 | CA2158762A1 Cyclic compounds and compositions which inhibit bone resorption |
| 10/27/1994 | CA2157599A1 35/31 kda subunit of the entamoeba histolytica adherence lectin |
| 10/27/1994 | CA2137833A1 Amino-sugars and glycoproteins, and methods for their preparation; pharmaceutical preparations containing these amino-sugars or glycoproteins, and the uses of these pharmaceuticalpreparations |
| 10/27/1994 | CA2137785A1 Immunoassay and test kit for thrombin-antithrombin iii complex |
| 10/26/1994 | EP0621342A1 Reagent and kit for determining isoprenylating activity and inhibition thereof |
| 10/26/1994 | EP0621341A2 Monoclonal antibodies to bovine cytokines |
| 10/26/1994 | EP0621340A1 Product and process for the production and purification of recombinant polypeptides |
| 10/26/1994 | EP0621339A2 Immunogenic human influenza A virus haemagglutinin polypeptides |
| 10/26/1994 | EP0621338A2 Immunosuppressant able to block the interleukin - 2 response |
| 10/26/1994 | EP0621337A1 Codon optimized DNA sequence for insect toxin AaIT |